Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

Characterizing advanced Parkinson's disease: OBSERVE-PD observational study results of 2615 patients.

Fasano A, Fung VSC, Lopiano L, Elibol B, Smolentseva IG, Seppi K, Takáts A, Onuk K, Parra JC, Bergmann L, Sail K, Jalundhwala Y, Pirtosek Z.

BMC Neurol. 2019 Apr 2;19(1):50. doi: 10.1186/s12883-019-1276-8.

2.

Diagnostic challenge: A case of late-onset spinal form cerebrotendinous xanthomatosis.

Mutlu D, Tuncer A, Gocmen R, Yalcin-Cakmakli G, Saygı S, Elibol B.

Neurology. 2019 Feb 26;92(9):438-439. doi: 10.1212/WNL.0000000000007015. No abstract available.

PMID:
30804055
3.

Effect of Restraint Stress on Plasma PTH Concentration and Its Molecular Targets Expressions in Wistar Rats.

Terzioglu-Usak S, Elibol B, Dalli T, Guler C, Aysan E.

Int J Endocrinol Metab. 2018 Sep 17;16(4):e66979. doi: 10.5812/ijem.66979. eCollection 2018 Oct.

4.

High Levels of SIRT1 Expression as a Protective Mechanism Against Disease-Related Conditions.

Elibol B, Kilic U.

Front Endocrinol (Lausanne). 2018 Oct 15;9:614. doi: 10.3389/fendo.2018.00614. eCollection 2018. Review.

5.

Turkish Standardization of Movement Disorders Society Unified Parkinson's Disease Rating Scale and Unified Dyskinesia Rating Scale.

Akbostanci MC, Bayram E, Yilmaz V, Rzayev S, Özkan S, Tokcaer AB, Saka E, Durmaz Celik FN, Barut BÖ, Tüfekcioglu Z, Acarer A, Balaban H, Erer S, Dogu O, Kibaroglu S, Aydin N, Hanagasi H, Elibol B, Emre M, Stebbins GT, Goetz CG.

Mov Disord Clin Pract. 2017 Nov 16;5(1):54-59. doi: 10.1002/mdc3.12556. eCollection 2018 Jan-Feb.

6.

Specific alterations in the circulating levels of the SIRT1, TLR4, and IL7 proteins in patients with dementia.

Kilic U, Elibol B, Uysal O, Kilic E, Yulug B, Sayin Sakul A, Babacan Yildiz G.

Exp Gerontol. 2018 Oct 1;111:203-209. doi: 10.1016/j.exger.2018.07.018. Epub 2018 Jul 30.

PMID:
30071285
7.

Striatal Neurotransmitter Release-related Presynaptic Proteins in L-dopa Induced Dyskinesia in a Model of Parkinsonism.

Çakmakli GY, Vural A, Koçak EE, Elibol B, Saka E.

Noro Psikiyatr Ars. 2018 Mar 19;55(1):73-79. doi: 10.5152/npa.2017.20531. eCollection 2018 Mar.

8.

Sensorimotor integration training in Parkinson`s disease.

Fil-Balkan A, Salci Y, Keklicek H, Armutlu K, Aksoy S, Kayihan H, Elibol B.

Neurosciences (Riyadh). 2018 Jul;23(4):208-215. doi: 10.17712/nsj.2018.3.20180021.

PMID:
30007996
9.

Use of anti-Parkinson medication during pregnancy: a case series.

Tüfekçioğlu Z, Hanağası H, Yalçın Çakmaklı G, Elibol B, Esmeli Tokuçoğlu F, Kaya ZE, Ertan S, Özekmekçi S, Emre M.

J Neurol. 2018 Aug;265(8):1922-1929. doi: 10.1007/s00415-018-8937-1. Epub 2018 Jun 20.

PMID:
29926223
10.

Thymoquinone activates MAPK pathway in hippocampus of streptozotocin-treated rat model.

Dalli T, Beker M, Terzioglu-Usak S, Akbas F, Elibol B.

Biomed Pharmacother. 2018 Mar;99:391-401. doi: 10.1016/j.biopha.2018.01.047.

PMID:
29367108
11.

Thymoquinone Can Improve Neuronal Survival and Promote Neurogenesis in Rat Hippocampal Neurons.

Beker M, Dallı T, Elibol B.

Mol Nutr Food Res. 2018 Mar;62(5). doi: 10.1002/mnfr.201700768. Epub 2018 Feb 12.

PMID:
29277983
12.

Epigenetic approach to early-onset Parkinson's disease: low methylation status of SNCA and PARK2 promoter regions.

Eryilmaz IE, Cecener G, Erer S, Egeli U, Tunca B, Zarifoglu M, Elibol B, Bora Tokcaer A, Saka E, Demirkiran M, Akbostanci C, Dogu O, Colakoglu B, Kenangil G, Kaleagasi H.

Neurol Res. 2017 Nov;39(11):965-972. doi: 10.1080/01616412.2017.1368141. Epub 2017 Aug 22.

PMID:
28830306
13.

Effects of prenatal binge-like ethanol exposure and maternal stress on postnatal morphological development of hippocampal neurons in rats.

Jakubowska-Dogru E, Elibol B, Dursun I, Yürüker S.

Int J Dev Neurosci. 2017 Oct;61:40-50. doi: 10.1016/j.ijdevneu.2017.06.002. Epub 2017 Jun 19.

PMID:
28636875
14.

The p.Thr11Met mutation in c19orf12 is frequent among adult Turkish patients with MPAN.

Olgiati S, Doğu O, Tufekcioglu Z, Diler Y, Saka E, Gultekin M, Kaleagasi H, Kuipers D, Graafland J, Breedveld GJ, Quadri M, Sürmeli R, Sünter G, Doğan T, Yalçın AD, Bilgiç B, Elibol B, Emre M, Hanagasi HA, Bonifati V.

Parkinsonism Relat Disord. 2017 Jun;39:64-70. doi: 10.1016/j.parkreldis.2017.03.012. Epub 2017 Mar 21.

PMID:
28347615
15.

Modulation of Cerebellar-Cortical Connections in Multiple System Atrophy Type C by Cerebellar Repetitive Transcranial Magnetic Stimulation.

Yildiz FG, Saka E, Elibol B, Temucin CM.

Neuromodulation. 2018 Jun;21(4):402-408. doi: 10.1111/ner.12589. Epub 2017 Mar 7.

PMID:
28266761
16.

Mutation analysis of the PARKIN, PINK1, DJ1, and SNCA genes in Turkish early-onset Parkinson's patients and genotype-phenotype correlations.

Erer S, Egeli U, Zarifoglu M, Tezcan G, Cecener G, Tunca B, Ak S, Demirdogen E, Kenangil G, Kaleagası H, Dogu O, Saka E, Elibol B.

Clin Neurol Neurosurg. 2016 Sep;148:147-53. doi: 10.1016/j.clineuro.2016.07.005. Epub 2016 Jul 4.

PMID:
27455133
17.

Mesenchymal stem cell therapy for the streptozotocin-induced neurodegeneration in rats.

Isik AT, Celik T, Ural AU, Tosun M, Ulusoy G, Elibol B.

Neurol Res. 2016 Apr;38(4):364-72. doi: 10.1080/01616412.2016.1139292. Epub 2016 Mar 1.

PMID:
27078696
18.

Default mode network connectivity is linked to cognitive functioning and CSF Aβ1-42 levels in Alzheimer's disease.

Celebi O, Uzdogan A, Oguz KK, Has AC, Dolgun A, Cakmakli GY, Akbiyik F, Elibol B, Saka E.

Arch Gerontol Geriatr. 2016 Jan-Feb;62:125-32. doi: 10.1016/j.archger.2015.09.010. Epub 2015 Oct 17.

PMID:
26515126
19.

Reply to Tzoulis et al.: Genetic and clinical heterogeneity of essential tremor.

Unal Gulsuner H, Gulsuner S, Mercan FN, Onat OE, Walsh T, Shahin H, Lee MK, Dogu O, Kansu T, Topaloglu H, Elibol B, Akbostanci C, King MC, Ozcelik T, Tekinay AB.

Proc Natl Acad Sci U S A. 2015 May 5;112(18):E2269. doi: 10.1073/pnas.1503756112. Epub 2015 Mar 30. No abstract available.

20.

Mitochondrial serine protease HTRA2 p.G399S in a kindred with essential tremor and Parkinson disease.

Unal Gulsuner H, Gulsuner S, Mercan FN, Onat OE, Walsh T, Shahin H, Lee MK, Dogu O, Kansu T, Topaloglu H, Elibol B, Akbostanci C, King MC, Ozcelik T, Tekinay AB.

Proc Natl Acad Sci U S A. 2014 Dec 23;111(51):18285-90. doi: 10.1073/pnas.1419581111. Epub 2014 Nov 24.

21.

Progressive neurodegenerative syndrome in a patient with X-linked agammaglobulinemia receiving intravenous immunoglobulin therapy.

Sag AT, Saka E, Ozgur TT, Sanal O, Ayvaz DC, Elibol B, Kurne AT.

Cogn Behav Neurol. 2014 Sep;27(3):155-9. doi: 10.1097/WNN.0000000000000037.

PMID:
25237746
22.

A new Turkish family with homozygous FBXO7 truncating mutation and juvenile atypical parkinsonism.

Yalcin-Cakmakli G, Olgiati S, Quadri M, Breedveld GJ, Cortelli P, Bonifati V, Elibol B.

Parkinsonism Relat Disord. 2014 Nov;20(11):1248-52. doi: 10.1016/j.parkreldis.2014.06.024. Epub 2014 Jul 22.

PMID:
25085748
23.

Cognitive profiling in relation to short latency afferent inhibition of frontal cortex in multiple system atrophy.

Celebi O, Temuçin ÇM, Elibol B, Saka E.

Parkinsonism Relat Disord. 2014 Jun;20(6):632-6. doi: 10.1016/j.parkreldis.2014.03.012. Epub 2014 Mar 19.

PMID:
24698055
24.

Evaluation of the valvular and biventricular functions in Parkinson patients using ergotamine-derived dopamine agonist: an observational study.

Ozer N, Yorgun H, Canpolat U, Elibol B.

Anadolu Kardiyol Derg. 2014 Mar;14(2):121-7. doi: 10.5152/akd.2014.4834. Epub 2014 Jan 14.

25.

Panthothenate kinase-associated neurodegeneration (PKAN) presenting with language deterioration, personality alteration, and severe parkinsonism.

Sakarya A, Öncü B, Elibol B.

J Neuropsychiatry Clin Neurosci. 2012 Fall;24(4):E13-4. doi: 10.1176/appi.neuropsych.11090228. No abstract available.

PMID:
23224463
26.

'Jaw clenching' in anti-Ri--antibody-associated paraneoplastic syndrome.

Bekircan-Kurt CE, Temucin Ç, Elibol B, Saka E.

Parkinsonism Relat Disord. 2013 Jan;19(1):132-3. doi: 10.1016/j.parkreldis.2012.05.013. Epub 2012 Jun 15. No abstract available.

PMID:
22704901
27.

Short latency afferent inhibition in Parkinson's disease patients with dementia.

Celebi O, Temuçin CM, Elibol B, Saka E.

Mov Disord. 2012 Jul;27(8):1052-5. doi: 10.1002/mds.25040. Epub 2012 May 17.

PMID:
22605543
28.

The effect of electrical stimulation in combination with Bobath techniques in the prevention of shoulder subluxation in acute stroke patients.

Fil A, Armutlu K, Atay AO, Kerimoglu U, Elibol B.

Clin Rehabil. 2011 Jan;25(1):51-9. doi: 10.1177/0269215510375919. Epub 2010 Aug 11.

PMID:
20702513
29.

EFNS guidelines on diagnosis and treatment of primary dystonias.

Albanese A, Asmus F, Bhatia KP, Elia AE, Elibol B, Filippini G, Gasser T, Krauss JK, Nardocci N, Newton A, Valls-Solé J.

Eur J Neurol. 2011 Jan;18(1):5-18. doi: 10.1111/j.1468-1331.2010.03042.x.

PMID:
20482602
30.

Transcranial sonography in Perry syndrome.

Saka E, Topcuoglu MA, Demir AU, Elibol B.

Parkinsonism Relat Disord. 2010 Jan;16(1):68-70. doi: 10.1016/j.parkreldis.2009.05.010. Epub 2009 Jun 7.

PMID:
19505837
31.

Enhanced cued recall and clock drawing test performances differ in Parkinson's and Alzheimer's disease-related cognitive dysfunction.

Saka E, Elibol B.

Parkinsonism Relat Disord. 2009 Nov;15(9):688-91. doi: 10.1016/j.parkreldis.2009.04.008. Epub 2009 May 15.

PMID:
19446489
32.

Reversible acute cognitive dysfunction induced by bilateral STN stimulation.

Cakmakli GY, Oruckaptan H, Saka E, Elibol B.

J Neurol. 2009 Aug;256(8):1360-2. doi: 10.1007/s00415-009-5103-9. Epub 2009 Apr 8.

PMID:
19353230
33.

Curcumin ameliorates impaired insulin/IGF signalling and memory deficit in a streptozotocin-treated rat model.

Isik AT, Celik T, Ulusoy G, Ongoru O, Elibol B, Doruk H, Bozoglu E, Kayir H, Mas MR, Akman S.

Age (Dordr). 2009 Mar;31(1):39-49. doi: 10.1007/s11357-008-9078-8. Epub 2008 Oct 8.

34.

DCTN1 mutations in Perry syndrome.

Farrer MJ, Hulihan MM, Kachergus JM, Dächsel JC, Stoessl AJ, Grantier LL, Calne S, Calne DB, Lechevalier B, Chapon F, Tsuboi Y, Yamada T, Gutmann L, Elibol B, Bhatia KP, Wider C, Vilariño-Güell C, Ross OA, Brown LA, Castanedes-Casey M, Dickson DW, Wszolek ZK.

Nat Genet. 2009 Feb;41(2):163-5. doi: 10.1038/ng.293. Epub 2009 Jan 11.

35.

Testicular teratoma and anti-N-methyl-D-aspartate receptor-associated encephalitis.

Eker A, Saka E, Dalmau J, Kurne A, Bilen C, Ozen H, Ertoy D, Oguz KK, Elibol B.

J Neurol Neurosurg Psychiatry. 2008 Sep;79(9):1082-3. doi: 10.1136/jnnp.2008.147611. No abstract available.

PMID:
18708569
36.

Mutation analysis of the PINK1 gene in 391 patients with Parkinson disease.

Kumazawa R, Tomiyama H, Li Y, Imamichi Y, Funayama M, Yoshino H, Yokochi F, Fukusako T, Takehisa Y, Kashihara K, Kondo T, Elibol B, Bostantjopoulou S, Toda T, Takahashi H, Yoshii F, Mizuno Y, Hattori N.

Arch Neurol. 2008 Jun;65(6):802-8. doi: 10.1001/archneur.65.6.802.

PMID:
18541801
37.

Newly diagnosed polymicrogyria in the eighth decade.

Tezer FI, Yildiz G, Oguz KK, Elibol B, Saygi S.

Epilepsia. 2008 Jan;49(1):181-3. doi: 10.1111/j.1528-1167.2007.01329_5.x. No abstract available.

38.

Management of vertebral stenosis complicated by presence of acute thrombus.

Canyigit M, Arat A, Cil BE, Sahin G, Turkbey B, Elibol B.

Cardiovasc Intervent Radiol. 2007 Mar-Apr;30(2):317-20.

PMID:
16988872
39.

Further clinical and genetic characterization of SPG11: hereditary spastic paraplegia with thin corpus callosum.

Olmez A, Uyanik G, Ozgül RK, Gross C, Cirak S, Elibol B, Anlar B, Winner B, Hehr U, Topaloglu H, Winkler J.

Neuropediatrics. 2006 Apr;37(2):59-66.

PMID:
16773502
40.

Management of a hemidystonic patient with thalamotomy, campotomy and cervical dorsal root entry zone operation.

Kahilogullari G, Ugur HC, Savas A, Dirik EB, Akbostanci MC, Elibol B, Kanpolat Y.

Stereotact Funct Neurosurg. 2005;83(4):180-3.

PMID:
16319522
41.

PARK6-linked autosomal recessive early-onset parkinsonism in Asian populations.

Hatano Y, Sato K, Elibol B, Yoshino H, Yamamura Y, Bonifati V, Shinotoh H, Asahina M, Kobayashi S, Ng AR, Rosales RL, Hassin-Baer S, Shinar Y, Lu CS, Chang HC, Wu-Chou YH, Ataç FB, Kobayashi T, Toda T, Mizuno Y, Hattori N.

Neurology. 2004 Oct 26;63(8):1482-5.

PMID:
15505170
42.

Mitochondrial complex I and IV activities in leukocytes from patients with parkin mutations.

Müftüoglu M, Elibol B, Dalmizrak O, Ercan A, Kulaksiz G, Ogüs H, Dalkara T, Ozer N.

Mov Disord. 2004 May;19(5):544-8.

PMID:
15133818
43.

Is the cell death in mesial temporal sclerosis apoptotic?

Uysal H, Cevik IU, Soylemezoglu F, Elibol B, Ozdemir YG, Evrenkaya T, Saygi S, Dalkara T.

Epilepsia. 2003 Jun;44(6):778-84.

44.

Isolation and characterization of channel catfish natural resistance associated macrophage protein gene.

Chen H, Waldbieser GC, Rice CD, Elibol B, Wolters WR, Hanson LA.

Dev Comp Immunol. 2002 Jul;26(6):517-31.

PMID:
12031412
45.

Nitric oxide is involved in ischemia-induced apoptosis in brain: a study in neuronal nitric oxide synthase null mice.

Elibol B, Söylemezoglu F, Unal I, Fujii M, Hirt L, Huang PL, Moskowitz MA, Dalkara T.

Neuroscience. 2001;105(1):79-86.

PMID:
11483302
46.

Apoptosis in brain biopsies of subacute sclerosing panencephalitis patients.

Anlar B, Söylemezoğlu F, Elibol B, Dalkara T, Aysun S, Köse G, Belen D, Yalaz K.

Neuropediatrics. 1999 Oct;30(5):239-42.

PMID:
10598834
47.

Circling seizures in a case with Wilson's disease.

Saka E, Elibol B, Saygi S.

Clin Electroencephalogr. 1999 Jul;30(3):118-21.

PMID:
10578476
48.

The genetic analysis of Turkish patients with Huntington's disease.

Ataç FB, Elibol B, Schaefer F.

Acta Neurol Scand. 1999 Sep;100(3):195-8.

PMID:
10478585
49.
50.

Rigid spine syndrome with fiber type disproportion.

Unal I, Erdem S, Elibol B, Tan E.

Muscle Nerve. 1999 Apr;22(4):542-3. No abstract available.

PMID:
10204795

Supplemental Content

Loading ...
Support Center